ELISA microplates background ELISA microplates background ELISA microplates background

WANTAI SARS-CoV-2 Ab ELISA

Total Ab ELISA for SARS-CoV-2 Virus (COVID-19)

Serological and Virological Markers of COVID-19

Wantai SARS-CoV-2 Ab ELISA is a highly sensitive and specific diagnostic kit intended for high-throughput, fast antibody screening for patients suspected for COVID-19 infection.

WANTAI SARS-CoV-2 Ab ELISA kit
Abstract background

Interested in learning more about Wantai SARS-CoV-2 Ab ELISA?

Contact Us Today
Checkmark

COVID-19 serological markers dynamics (Total Ab/IgM/IgG):

  • 20%-40% of the patients developed antibodies on days 0-7 after onset
  • 60%-70% of the patients developed antibodies on days 8-11 after onset
  • > 90% of the patients had detectable levels of antibodies starting from day 12 after onset
Checkmark

COVID-19 molecular marker dynamics (RNA):

  • RNA was detected in 60-75% of the patients on days 0-8 after onset
  • 60%-70% of the patients developed antibodies on days 8-11 after onset
  • >RNA levels decrease to 40-50% starting from day 9 after onset

For prescription use only.
For in vitro diagnostic use only.
For use under Food and Drug Administration’s Emergency Use Authorization (EUA) only.